NEW YORK (GenomeWeb) – Thermo Fisher Scientific took $40.4 million in charges during the second quarter related to severance, the company disclosed in its Form 10-Q.
Registering provides access to this and other free content.
Already have an account?Login Now.
The San Diego Union Tribune wonders whether Medicare is ready for personalized medicine.
Jun Wang, the chief executive of BGI, has stepped down.
In PNAS this week: human T cell editing with CRISPR, retrotransposons acting as insulators, and more.
The New York Times' George Johnson muses on cancer's roots in multicellularity.